These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 164279)

  • 1. The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.
    Hurwitz E; Levy R; Maron R; Wilchek M; Arnon R; Sela M
    Cancer Res; 1975 May; 35(5):1175-81. PubMed ID: 164279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies.
    Levy R; Hurwitz E; Maron R; Arnon R; Sela M
    Cancer Res; 1975 May; 35(5):1182-6. PubMed ID: 164280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed tumor chemotherapy.
    Arnon R
    Compr Ther; 1978 Apr; 4(4):68-73. PubMed ID: 348397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fab dimers of antitumor immunoglobulins as covalent carriers of daunomycin.
    Hurwitz E; Maron R; Arnon R; Sela M
    Cancer Biochem Biophys; 1976 May; 1(4):197-202. PubMed ID: 975021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.
    Mantovani A; Polentarutti N; Luini W; Peri G; Spreafico F
    J Natl Cancer Inst; 1979 Jul; 63(1):61-6. PubMed ID: 286835
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.
    Mantovani A
    Cancer Res; 1977 Mar; 37(3):815-20. PubMed ID: 837378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Daunomycin and adriamycin antitumor cell antibody conjugates.
    Hurwitz E; Levy R; Maron R
    Isr J Med Sci; 1975 Dec; 11(12):1396. PubMed ID: 1218993
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted anti-tumor agents and their cytotoxicity on gastric cancer cells in vitro.
    Li S; Zhang XY; Chen XT; Fan DM; Tan LS; Pan HZ; Huang LQ
    Chin Med J (Engl); 1990 May; 103(5):376-9. PubMed ID: 2118053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
    Ohta S; Igarashi S; Honda A; Sato S; Hanai N
    Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theta antigen and immunogolbulin on a tissue-cultured mouse lymphoma.
    Boylston AW
    Immunology; 1973 May; 24(5):851-7. PubMed ID: 4541405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation of 7S-immunoglobulins (IgG), detected in spleen cells and sera of mice in the early stages of Rauscher leukemia].
    Ter-Grigorov VS; Dzagurov SG; Dorfman NA; Shevelev BI
    Biull Eksp Biol Med; 1974 Nov; 78(11):82-5. PubMed ID: 4614878
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing.
    Braslawsky GR; Edson MA; Pearce W; Kaneko T; Greenfield RS
    Cancer Res; 1990 Oct; 50(20):6608-14. PubMed ID: 2208123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and properties of an antiplasma cell serum directed against a defined plasmacytoma cell population.
    Proctor ML; Herscowitz HB
    J Immunol; 1975 Dec; 115(6):1642-9. PubMed ID: 1184969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
    Prager MD; Granatek CH; Ludden CM
    Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A differential interaction of daunomycin, adriamycin, and N-trifluoroacetyladriamycin 14-valerate with mouse peritoneal macrophages.
    Facchinetti T; Raz A; Goldman R
    Cancer Res; 1978 Nov; 38(11 Pt 1):3944-9. PubMed ID: 212183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between cytotoxicity, biochemical effects, drug levels, and therapeutic effectiveness of daunomycin and adriamycin on Sarcoma 180 ascites in mice.
    Silvestrini R; Lenaz L; Di Fronzo G; Sanfilippo O
    Cancer Res; 1973 Nov; 33(11):2954-8. PubMed ID: 4748447
    [No Abstract]   [Full Text] [Related]  

  • 17. [Production of adriamycin covalent binding to monoclonal antibody OC-859 and its anti-tumor activities].
    Zhang L
    Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):346-8, 387. PubMed ID: 1804604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates.
    Dillman RO; Johnson DE; Ogden J; Beidler D
    Mol Biother; 1989; 1(5):250-5. PubMed ID: 2515870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.
    Trail PA; Willner D; Lasch SJ; Henderson AJ; Greenfield RS; King D; Zoeckler ME; Braslawsky GR
    Cancer Res; 1992 Oct; 52(20):5693-700. PubMed ID: 1382845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.